WordNet
- a substance that exerts some force or effect
- a businessman who buys or sells for another in exchange for a commission (同)factor, broker
- any agent or representative of a federal agency or bureau (同)federal agent
- a representative who acts on behalf of other persons or organizations
- an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
- how long something has existed; "it was replaced because of its age"
- a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
- begin to seem older; get older; "The death of his wife caused him to age fast"
- make older; "The death of his child aged him tremendously"
- of or pertaining to or involving the heart and blood vessels; "cardiovascular conditioning"
PrepTutorEJDIC
- 『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
- 〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる
- 心臓と血管の(に影響する)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 心血管MRIの臨床的有用性 clinical utility of cardiovascular magnetic resonance imaging
- 2. 腎移植レシピエントにおける心血管疾患の危険因子 risk factors for cardiovascular disease in the renal transplant recipient
- 3. 分子標的薬である血管新生阻害剤の毒性：心血管系への影響 toxicity of molecularly targeted antiangiogenic agents cardiovascular effects
- 4. 心血管疾患の二次予防 secondary prevention of cardiovascular disease
- 5. 原発性（本態性）高血圧における治療選択：臨床試験 choice of therapy in primary essential hypertension clinical trials
English Journal
- The decomposition of protoporphyrin IX by ultrasound is dependent on the generation of hydroxyl radicals.
- Xu H1, Sun X1, Yao J2, Zhang J3, Zhang Y2, Chen H2, Dan J3, Tian Z3, Tian Y4.
- Ultrasonics sonochemistry.Ultrason Sonochem.2015 Nov;27:623-30. doi: 10.1016/j.ultsonch.2015.04.024. Epub 2015 Apr 24.
- The ultrasound activation of certain drugs, such as porphyrins, could cause synergistic cytotoxic effects on cells. Both sonomechanical and sonochemical effects occur and the latter play a critical role because antioxidant agents could exert significant protective effects against the cytotoxicity. T
- PMID 25934126
- Genetics of Resistant Hypertension: a Novel Pharmacogenomics Phenotype.
- El Rouby N1, Cooper-DeHoff RM.
- Current hypertension reports.Curr Hypertens Rep.2015 Sep;17(9):583.
- Resistant hypertension (RHTN), defined as an uncontrolled blood pressure despite the use of multiple antihypertensive medications, is an increasing clinical problem associated with increased cardiovascular (CV) risk, including stroke and target organ damage. Genetic variability in blood pressure (BP
- PMID 26198781
- Perfluoroalkyl substances (PFAS) including structural PFOS isomers in plasma from elderly men and women from Sweden: Results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS).
- Salihovic S1, Kärrman A2, Lind L3, Lind PM4, Lindström G2, van Bavel B2.
- Environment international.Environ Int.2015 Sep;82:21-7. doi: 10.1016/j.envint.2015.05.003. Epub 2015 May 22.
- Per- and polyfluoroalkyl substances (PFASs) are a class of compounds with unique chemical properties that have been shown useful in a wide variety of applications because they provide materials with reduced surface tension and exceptional non-stick properties. PFASs are commonly found in impregnatio
- PMID 26001496
Japanese Journal
- Periprocedural Evaluation and Management against Cerebral Hyperperfusion Syndrome after Carotid Artery Stenting in Japan: A Nationwide Questionnaire Survey
- 脳神経血管内治療 11(7), 341-350, 2017
- NAID 130005815394
- Long term effects of cilostazol in a dog with sick sinus syndrome
- Ｔｈｅ Ｊｏｕｒｎａｌ ｏｆ Ｖｅｔｅｒｉｎａｒｙ Ｍｅｄｉｃａｌ Ｓｃｉｅｎｃｅ, 2017
- NAID 130005631474
- Ventricular Tachycardia as a Complication of Ledipasvir and Sofosbuvir Treatment for HCV Infection
- Internal Medicine 56(7), 787-790, 2017
- NAID 130005530195
Related Links
- Cardiovascular Agent a medicinal preparation used in the treatment of heart failure and disorders of vascular tension. Cardiovascular agents include cardiac glycosides, vasodilators, and vasoconstrictors. Most cardiac glycosides and ...
- Cardiovascular agent information including symptoms, causes, diseases, symptoms, treatments, and other medical and health issues. ... Introduction: Cardiovascular agent Description of Cardiovascular agent Cardiovascular agent ...
Related Pictures
★リンクテーブル★
| リンク元 | 「循環器系薬」「心血管治療薬」「循環器作用薬」「心血管作動薬」「心血管系薬剤」 |
| 関連記事 | 「agent」「cardiovascular」「age」 |
「循環器系薬」
「心血管治療薬」
「循環器作用薬」
「心血管作動薬」
「心血管系薬剤」
「agent」
- n.
- 代行者、代理人。代理業者
- 政府職員、官吏
- ある後位をする人、ある作用をするもの。動員、動力因、作用因。(文法)動作主。科学的変化を起こさせるもの、薬品、～剤。病原体
- 関
- agonist、agonistic、attorney、delegate、drug、etiologic agent、fomes、fomites、mediator、pathogen、pathogenic、pharmaceutical preparation、vector、vehicle
「cardiovascular」
- adj.
- 心血管の、心血管系の、循環器の、循環器系の、心血管性の
「age」
- n.
- 年齢、歳
- v.
- 加齢する、熟成する